language_icon
EN
HI

Gennex Laboratories Share price

GENNEX

10.31

0.18 (-1.72%)
Last updated on 23 Apr, 2026 | 15:29 IST
Today's High

10.59

Today's Low

10.21

52 Week Low

7.05

52 Week High

17.25

Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

Gennex Laboratories Chart

Gennex Laboratories Share Key Metrics

Volume
1.95 L
Market Cap
254.85 CR
LTQ@LTP
64@10.31
ATP
10.38
Var Margin
26.76 %
Circuit Range
8.4-12.58
Delivery %
76.58 %
Value
20.27 L
ASM/GSM
No
Market Lot
1

Summary

23 Apr, 2026 | 15:29 को, Gennex Laboratories का शेयर प्राइस आज ₹10.31 पर है, जो दिन के लिए 0.18% की -1.72 दर्शाता है। स्टॉक की इंट्राडे मूवमेंट ₹10.21 और ₹10.59 के बीच रही है, जबकि 52‑सप्ताह के आधार पर यह ₹7.05 से ₹17.25 तक रही है। ट्रेडिंग गतिविधि के मामले में, Gennex Laboratories ने 195236 शेयरों का वॉल्यूम रिकॉर्ड किया है, जिसका मार्केट कैपिटलाइज़ेशन ₹242947674 है। स्टॉक की एवरेज ट्रेडेड प्राइस ₹1038 है, जबकि लास्ट ट्रेडेड क्वांटिटी एट लास्ट ट्रेडेड प्राइस (LTQ@LTP) 64,1031 रही। यह स्टॉक ₹8.4-12.58 की सर्किट रेंज में ट्रेड करता है, और आज का कारोबार मूल्य ₹20.27 L है। दिन के लिए डिलीवरी परसेंटेज 76.58% रही। इसके अतिरिक्त, Gennex Laboratories वर्तमान में No फ्रेमवर्क के तहत आता है और 1 के मार्केट लॉट साइज़ में ट्रेड करता

Gennex Laboratories Fundamentals

View More
P/E Ratio

14.47

P/B Ratio

1.16

Div. Yield

0

Sector P/E

64.34

Sector P/B

3.51

Sec. Div. Yield

0.57

Gennex Laboratories Resistance and Support

Pivot 10.56

Resistance

First Resistance

10.72

Second Resistance

10.95

Third Resistance

11.11

Support

First Support

10.33

Second Support

10.17

Third Support

9.94

Gennex Laboratories Shareholding Pattern

View More
  • 2016-17
  • 2018-19
  • 2019-20
  • 2020-21
  • 2021-22
  • 2022-23
  • 2023-24
  • 2024-25
  • 2025-26
  • 2026-27
Total Promoters
Segment
Percent

Total Promoters

23.63%

Mutual Fund

0%

Insurance

0%

Foreign Institutional Investors

0%

Domestic Institutional Investors

0%

Retail

76.37%

Others

0%

Total Promoters
MAR '26
23.63%

Gennex Laboratories Corporate Actions

DateAgenda
2026-04-16Others
2026-02-14Quarterly Results

Gennex Laboratories News

Gennex Laboratories Ltd - 531739 - Board Meeting Outcome for Revised Outcome

Gennex Laboratories board approved convening an EGM on May 12, 2026, to regularize Additional Director Ms. Khushbu Kachhawa. NSDL has been appointed to facilitate e-voting for the EGM.
Apr 17 2026 18:04:00

Gennex Laboratories Ltd - 531739 - Board Meeting Outcome for For Meeting Held On April 16, 2026 Of Gennex Laboratories Limited To Conduct EGM

Gennex Laboratories board approved calling an EGM on May 12, 2026, to regularize additional director Ms. Khushbu Kachhawa. NSDL will facilitate e-voting for the meeting, scheduled from May 09-11, 2026.
Apr 16 2026 17:04:00

Gennex Laboratories Ltd - 531739 - Board Meeting Intimation for Meeting To Be Held On Thursday, April 16, 2026

Gennex Laboratories will convene a Board Meeting on April 16, 2026, to discuss holding an Extraordinary General Meeting (EGM). The EGM's primary agenda is to regularize the appointment of Additional Director Ms. Khushbu Kachhawa.
Apr 08 2026 15:04:00
Read More

About Gennex Laboratories AboutThe

NSE : 0  
BSE : 531739  
ISIN : INE509C01026  

PRUDENTIAL PHARMACEUTICALS LIMITED was originally incorporated under the name of Pharmasia Drugs and Chemicals Private Limited on 25th June 1985 in the state of Karnataka. The Company was subsequently shifted to Andhra Pradesh with effect from 29th March 1990. The Company has been promoted by Pharmasia Limited a Company registered under the Companies Act 1956 and having its registered office at 49 BHEL Enclave Akbar Road Secunderabad - 500 003. The Company had acquired a sick bulk drug manufacturing unit of SPS Chemicals Private Limited a sick unit assisted by the Andhra Pradesh State Financial Corporation Limited located at 133 Bollaram Medak Dist. in an auction in January 1993 by paying a lumpsum consideration of Rs.13.25 lacs and undertaking to pay off the term loan overdues amounting to Rs.24 lacs to APSFC which has since been paid off.The Company became a Deemed Public Limited Company with effect from 6th February 1993 as per the provisions of section 43A(1) of the Companies Act 1956. The Company was converted to a Public Limited Company by a resolution passed by its members at the Extraordinary General Body Meeting held on 3rd November 1994. A fresh certificate of incorporation consequent upon the conversion of the Company was issued by the Registrar of Companies Andhra Pradesh on 15th February 1995. The Company''s name was subsequently changed to Prudential Pharmaceuticals Limited and a fresh certificate of incorporation consequent upon change of name of the Company was issued by the Registrar of Companies Andhra Pradesh on 22nd February 1995.Mr.Vinod Baid & his associates acquired the entire holding of Pharmasia Limited amounting to 140018 shares at their face value (the consideration for which has been paid in cash) in November 1994 with a view to implement the project to set up facilities for manufacturing bulk drugs.The controlling interest held by the erstwhile promoter group was acquired by Mr.Vinod Baid & Associates by transfer of shares by following the procedure set out in the Companies Act 1956 and the rules framed there under i.e. by executing transfer deeds in prescribed form in favour of the transferees.At the time of take-over the Company had certain plant and machinery which has been detailed elsewhere in the prospectus and had also placed orders for certain other plant and machinery. After the takeover the company under the new management had taken up the implementation of the project in right earnest. The products were identified additional equipment required (other than those already available and those ordered) were acquired and the manpower required for manning the project were hired. The trial production was completed in September 1995 and the Commercial Production has already commenced.The Details of the position of the Company as at 31st March 1994 the cut-off date considered by Mr. Vinod Baid & Associates for the purpose of acquisition of controlling interest in the Company has been given as under:

Read More

Gennex Laboratories Management

NamePosition
Dinesh Kumar KejriwalCompany Secretary & Compliance Officer
Arihant BaidManaging Director
View More

Gennex Laboratories FAQs

Gennex Laboratories शेयर का खरीद मूल्य 10.31 है। लाइव प्राइस और तत्काल ट्रेडिंग के लिए, आप अपने चॉइस ट्रेडिंग खाते में लॉगिन कर सकते हैं या चॉइस के साथ मुक्त डीमैट खाता खोल सकते हैं।

Gennex Laboratories शेयर खरीदने के लिए अपने चॉइस ट्रेडिंग खाते में लॉगिन करें, या चॉइस डीमैट खाता खोल, फिर फंड जोड़ें, कंपनी का नाम खोजें, अपना ऑर्डर टाइप चुनें और ट्रेड प्लेस करें।

Gennex Laboratories शेयर का प्राइस-टू-अर्निंग्स (पी/ई) रेशियो 14.47 है। आप सापेक्ष मूल्यांकन के लिए इसकी तुलना सेक्टर के औसत से कर सकते हैं।

Gennex Laboratories शेयर का प्राइस-टू-बुक (पी/बी) रेशियो 1.16 है। यह शेयर के मूल्य की तुलना उसकी बुक वैल्यू से करने में उपयोगी है।

Gennex Laboratories शेयर का प्राइस-टू-बुक (पी/बी) रेशियो 3.51 है। यह शेयर के मूल्य की तुलना उसकी बुक वैल्यू से करने में उपयोगी है।

Gennex Laboratories का मार्केट कैप 254.85 CR है। यह कंपनी के आकार की श्रेणी और ट्रेडिंग लिक्विडिटी को दर्शाता है।

Gennex Laboratories शेयर का 52 सप्ताह का उच्चतम और न्यूनतम मूल्य 17.25 और 7.05 है। ये मूल्य मूल्य सीमाएं, ट्रेडिंग रेंज, अस्थिरता, संभावित सपोर्ट/रेजिस्टेंस और मूल्य गति को दर्शाते हैं।

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost